Literature DB >> 1848290

Epstein-Barr virus receptors but not viral DNA are present in normal and malignant oral epithelium.

A A Talacko1, C G Teo, B E Griffin, N W Johnson.   

Abstract

The presence and distribution of Epstein-Barr Virus receptors (EBVR's) on a range of normal (n = 18), dysplastic (n = 10) and malignant (n = 20) oral mucosa were studied by immunocytochemical methods using the monoclonal antibodies (MAb's) HB5 and B2. EBVR's were demonstrated as membrane staining of the spinous layers of normal non- and parakeratinized epithelium, indicating that EBVR's are differentiation-linked. This distribution was retained in dysplastic epithelium. Tissue from oral squamous cell carcinomas (SCC's) showed variable reactivity of only a few cells scattered randomly within the samples. Furthermore, a sensitive in situ hybridization (ISH) technique was used to determine if Epstein-Barr virus (EBV) was present in normal (n = 15) and oral squamous cell carcinoma tissue (n = 20). No EBV DNA was demonstrated within either normal or malignant epithelium, suggesting that the virus does not persist in normal oral stratified squamous epithelium nor is there any evidence for a role in oral carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848290     DOI: 10.1111/j.1600-0714.1991.tb00882.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  7 in total

Review 1.  Epstein-Barr virus tissue tropism: a major determinant of immunopathogenesis.

Authors:  L Hutt-Fletcher
Journal:  Springer Semin Immunopathol       Date:  1991

2.  Oral dysplasia and squamous cell carcinoma: correlation between increased expression of CD21, Epstein-Barr virus and CK19.

Authors:  Ru Jiang; Xin Gu; Tara N Moore-Medlin; Cherie-Ann Nathan; Lindsey M Hutt-Fletcher
Journal:  Oral Oncol       Date:  2012-04-16       Impact factor: 5.337

3.  Oral manifestations as predictors of immune suppression in a HIV-/AIDS-infected population in south India.

Authors:  Gaurav Sharma; Keerthilatha M Pai; Suhas Setty; John T Ramapuram; Archna Nagpal
Journal:  Clin Oral Investig       Date:  2008-07-31       Impact factor: 3.573

4.  Ghrelin and obestatin expression in oral squamous cell carcinoma: an immunohistochemical and biochemical study.

Authors:  Manar M Alnema; Suleyman Aydin; Yusuf Ozkan; Adile F Dagli; Hanifi I Ozercan; Nezahat Yildirim; Ibrahim Sahin; Aziz Karaoglu; Nermin Kilic; Mustafa Yilmaz; Mehmet R Ozercan; Emir Donder
Journal:  Mol Cell Biochem       Date:  2010-01-03       Impact factor: 3.396

5.  Laser-capture microdissection of oropharyngeal epithelium indicates restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells.

Authors:  Ru Jiang; Xin Gu; Cherie-Ann Nathan; Lindsey Hutt-Fletcher
Journal:  J Oral Pathol Med       Date:  2008-08-15       Impact factor: 4.253

6.  The significance of Epstein Barr virus (EBV) & DNA topoisomerase II alpha (DNA-Topo II alpha) immunoreactivity in normal oral mucosa, oral epithelial dysplasia (OED) and oral squamous cell carcinoma (OSCC).

Authors:  Ali A Shamaa; Manal M Zyada; Mathias Wagner; Sally S Awad; Mohamed M Osman; Ali A Abdel Azeem
Journal:  Diagn Pathol       Date:  2008-11-20       Impact factor: 2.644

7.  Assessing the potential association between Epstein-Barr virus and oral squamous cell carcinoma: a systematic review and meta-analysis.

Authors:  Shivaranjhany Sivakumar; Archana A Gupta; Nik Mohd Mazuan Nik Mohd Rosdy; Annapurny Venkiteswaran; A Thirumal Raj; Kamran Habib Awan
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.